A rating of 98 puts Tscan Therapeutics Inc (TCRX) near the top of the Biotechnology industry according to InvestorsObserver. Tscan Therapeutics Inc's score of 98 means it scores higher than 98% of stocks in the industry. Tscan Therapeutics Inc also received an overall rating of 86, putting it above 86% of all stocks. Biotechnology is ranked 49 out of the 148 industries.
TCRX has an Overall Score of 86. Find out what this means to you and get the rest of the rankings on TCRX!
Trying to find the best stocks can be a daunting task. There are a wide variety of ways to analyze stocks in order to determine which ones are performing the strongest. InvestorsObserver makes the entire process easier by using percentile rankings that allows you to easily find the stocks who have the strongest evaluations by analysts.
This ranking system incorporates numerous factors used by analysts to compare stocks in greater detail. This allows you to find the best stocks available in any industry with relative ease. These percentile-ranked scores using both fundamental and technical analysis give investors an easy way to view the attractiveness of specific stocks. Stocks with the highest scores have the best evaluations by analysts working on Wall Street.
What's Happening With Tscan Therapeutics Inc Stock Today?
Tscan Therapeutics Inc (TCRX) stock is trading at $4.18 as of 1:09 PM on Tuesday, Nov 21, a drop of -$0.43, or -9.33% from the previous closing price of $4.61. The stock has traded between $4.14 and $4.72 so far today. Volume today is above average. So far 123,516 shares have traded compared to average volume of 73,507 shares.
Click Here to get the full Stock Report for Tscan Therapeutics Inc stock.
Share this article:
Stay In The Know
Subscribe to our daily morning update newsletter and never miss out on the need-to-know market news, movements, and more.
Thank you for signing up! You're all set to receive the Morning Update newsletter
